Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vantis

Explore full profile

Vantis is a Munich-based startup that develops digital solutions to improve the lives of millions of patients with cardiovascular diseases

Munich, GermanyFounded 2019Biotech & Life Sciences
Valuation $50–100M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vantis and the history behind them.

About Vantis

Vantis Health is a healthcare startup focused on improving the quality of life for individuals with chronic illnesses, particularly those at risk of heart disease. Operating primarily in Germany, where over 40 million people live with chronic conditions, Vantis Health aims to fill a significant gap in the healthcare system. Traditional healthcare often focuses on emergency treatment, leaving patients to manage their chronic conditions on their own in everyday life. Vantis Health addresses this issue by providing comprehensive support through its digital platform.

The company’s primary offering is a mobile app designed to help patients manage their chronic conditions more effectively. The app provides daily reminders for medication, tracks vital health metrics like blood pressure, and offers personalized exercise and nutrition plans. Users can also export therapy reports to share with their healthcare providers, ensuring a coordinated approach to their treatment.

Vantis Health serves a broad range of clients, including individuals with chronic heart conditions such as coronary heart disease (CHD) and those at high risk of heart attacks. The app is particularly beneficial for older adults and those who require consistent monitoring and support to manage their health.

The startup operates in the digital health market, a rapidly growing sector driven by increasing healthcare costs and the need for more efficient, patient-centered care solutions. Vantis Health’s business model is based on a subscription service, where users pay a monthly or annual fee to access the app’s features. This recurring revenue model ensures a steady income stream for the company.

In summary, Vantis Health leverages technology to provide continuous care and support for individuals with chronic illnesses, helping them lead healthier lives. The company’s innovative approach addresses a critical need in the healthcare system, making it a promising player in the digital health market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Munich, Germany
Employees
47
Open positions
24
Dealroom signal
77.2/100
Industry
Health
Sub-industry
Pharmaceutical, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Remote Monitoring, Biotech and Pharma, Hard Tech, Digital Pharma, remote health monitoring, DT and LS
Technology
Mobile app
Business model
SaaS
Client focus
b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VCOther financing Mar 2025 $11M $44M Twip Impact Ventures · Bayern Kapital · Firstminute Capital · b2venture ↗
EARLY VCOther financing Apr 2021 $4.2M $17M Firstminute Capital · b2venture —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Vantis website traffic

Latest recorded traffic for Vantis is 930 monthly website visits, down 74.9% over the last three months. Vantis's team grew 20.5% over the past year.

Latest monthly visits930 3-month web change-74.9% 1-year team growth+20.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Other known investors5 additional known investors

  • denkapparat
  • Goodface Capital
  • M4 Capital
  • Philipp Roesch-Schlanderer
  • YZR Capital
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇩🇪 Germany100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vantis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vantis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.